Tumor Necrosis Factor-α and Interleukin-6 Concentrations in Cerebrospinal Fluid of Dogs After Seizures

Journal of Veterinary Internal Medicine

Volumn 28, Issue 6, 2014, Pages 1775-1781

  Merbl, Y ^a   Sommer, A ^a   Chai, O ^a   Aroch, I ^a   Zimmerman, G ^a   Friedman, A ^b   Soreq, H ^a   Shamir, M H ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antiinflammatory; Canine; Cytokine; Idiopathic epilepsy

Indexed keywords

CANIS FAMILIARIS;

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BLOOD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; DOG; DOG DISEASE; FEMALE; MALE; PROSPECTIVE STUDY; SEIZURE; VETERINARY;

ANIMALS; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; INTERLEUKIN-6; MALE; PROSPECTIVE STUDIES; SEIZURES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84911480482     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/jvim.12462     Document Type: Article

References (38)

1. Chang Y, Mallor DJ, Anderson TJ. Idiopathic epilepsy in dogs: Owners' perspective on management with phenobarbital and/or potassium bromide. J Small Anim Pract 2006;47:574-581.
2. Pákozdy A, Leschnik M, Tichy AG, et al. Retrospective clinical comparison of idiopathic versus symptomatic epilepsy in 240 dogs with seizures. Acta Vet Hung 2008;56:471-483.
3. Klopmamm VT, Rambeck B, Tipold A. Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. J Small Anim Pract 2007;48:134-138.
4. Löscher W. Animal models of intractable epilepsy. Prog Neurobiol 1997;59:239-258.
5. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. J Pharmacol 2006;147:232-240.
6. Gnatek Y, Zimmerman G, Goll Y, et al. Acetyl choline esterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis. Front Mol Neurosci 2012;5:1-10.
7. Librizzi L, Noè F, Vezzani A, et al. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 2012;72:82-90.
8. Vezzani A, Granata T. Brain inflammation in epilepsy: Experimental and clinical evidence. Epilepsia 2005;46:1724-1743.
9. Becher B, Prat A, Antel JP. Brain-immune connection: Immunoregulatory properties of CNS-resident cells. Glia 2000;29:293-304.
10. Nguyen MD, Julien JP, Rivest S. Innate immunity: The missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 2002;3:216-227.
11. Siv M. Role of inflammation in epilepsy and treatment with IVIg. Intractable childhood epilepsy alliance drug information rotation, Wingate University School of Pharmacy, 5.17.2010. Internet sheet: http://www.ice-epilepsy.org/role-of-inflammation-in-epilepsy-and-treatment-with-ivig.html. Accessed January 30, 2014.
12. Billiau AD, Wouters CH, Lgae LG. Epilepsy and the immune system: Is there a link? Eur J Paediatr Neurol 2005;9:29-42.
13. Van Rijckevorsel K. Immunological mechanisms in the aetiology of epilepsy. BioDrugs 1999;12:115-127.
14. Beattie EC, Stellwagen D, Morishita W, et al. Control of synaptic strength by glial TNF-alpha. Science 2002;295:2282-2285.
15. Stellwagen D, Beattie EC, Seo JY, et al. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005;25:3219-3228.
16. Balosso S, Ravizza T, Perego C, et al. Tumor necrosis factor alpha inhibits seizures in mice via p75 receptors. Ann Neurol 2005;57:804-812.
17. Cunningham AJ, Murray CA, O'Neill LA, et al. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 1996;203:17-20.
18. Probert L, Akassoglou K, Pasparakis M, et al. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci USA 1995;92:11282-11294.
19. Schwartz M, Puff C, Stein VM, et al. Pathogenetic factors for excessive IgA production: Th2-dominated immune response in canine steroid-responsive meningitis-arteritis. Vet J 2011;187:260-266.
20. Tipold A, Moore P, Zurbriggen A, et al. Early T cell response in the central nervous system in canine distemper virus infection. Acta Neuropathol 1999;97:45-56.
21. Spitzbarth I, Bock P, Haist V, et al. Prominent microglial activation in the early proinflammatory immune response in naturally occurring canine spinal cord injury. J Neuropathol Exp Neurol 2011;70:703-714.
22. Maiolini A, Otten M, Hewicker-Trautwein M, et al. Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis. BMC Vet Res 2013;9:23.
23. Chrisman CL. Cerebrospinal fluid analysis, Moore, M.P.: Diseases of the spine. Vet Clin North Am Small Anim Pract. 1992;22:796-800.
24. Ozkara C, Vigevano R. Immuno and anti-inflammatory therapies in epileptic disorders. Epilepsia 2011;52:45-51.
25. Marchi N, Granata T, Freri E, et al. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 2011;6:e18200.
26. Wallenstein MC. Attenuation of penicillin models of epilepsy by nonsteroidal anti-inflammatory drugs. Exp Neurol 1987;98:152-160.
27. Minami M, Kuraishi Y, Yamaguchi T, et al. Convulsants induce interleukin-1 beta messenger RNA in rat brain. Biochem Biophys Res Commun 1990;171:832-837.
28. Sonmez FM, Serin HM, Alver A, et al. Blood levels of cytokines in children with idiopathic partial and generalized epilepsy. Seizure 2013;22:517-521.
29. Sinha S, Patil SA, Jayalekshmy V, et al. Do cytokines have any role in epilepsy? Epilep Res 2008;82:171-176.
30. Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803.
31. Vezzani A, Ravizza T, Balosso S, et al. Glia as a source of cytokines: Implications for neuronal excitability and survival. Epilepsia 2008;49:24-32.
32. Tutuncuoglu S, Kutukculer N, Kepe L, et al. Proinflammatory cytokines, prostaglandins and zinc in febrile convulsions. Pediatr Int 2001;43:235-239.
33. Samland H, Huitron-Resendiz S, Masliah E, et al. Profound increase in sensitivity to glutamatergic but not cholinergic agonistinduced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res 2003;73:176-187.
34. De Simoni MG, Perego C, Ravizza T, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000;12:2623-2633.
35. Ravizza T, Rizzi T, Perego M, et al. Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia 2005;46:113-117.
36. Mcquarrie I, Anderson JA, Ziegler MR. Observations on the antagonistic effects of posterior pituitary and cortico-adrenal hormones in the epileptic subject. J Clin Endocrinol Metabol 1942;2:406-410.
37. Tomkins O, Kaufer D, Korn A, et al. Frequent blood-brain barrier disruption in the human cerebral cortex. Cell Mol Neurobiol 2001;21:675-691.
38. Korn A, Golan H, Melamed I, et al. Focal cortical dysfunction and blood-brain barrier disruption in patients with post-concussion syndrome. J Clin Neurophysiol 2005;22:1-9.